HAVN Life Sciences Inc.

CSE: HAVN, 5NP.F

Company Logo

Company Overview

Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. 

Financial Highlights

$335,016

Revenue (ttm)

$89,693

Gross Profit (ttm)

-$0.19

Diluted EPS (ttm)

Management Team

Mr. Tim Moore
Interim CFO, CEO & Chairman

Ms. Jenna Pozar
Chief Operations Officer

Mr. Paul More
Controller

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$3,722,736

Shares Outstanding
66,771,000

Shares Short (% of Float)
()

Insider Ownership
1%